Quick Answer
ProPhase Labs, Inc. reported R&D Expense of $594.0 thousand for fiscal year 2024.
ProPhase Labs, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $594.0K | -57.6% |
| 2023 | $1.40M | +115.0% |
| 2022 | $652.0K | +25.4% |
| 2021 | $520.0K | -17.9% |
| 2020 | $633.0K | +90.7% |
| 2019 | $332.0K | -16.6% |
| 2018 | $398.0K | -7.7% |
| 2017 | $431.0K | +20.4% |
| 2016 | $358.0K | +5.3% |
| 2015 | $340.0K | -74.3% |
| 2014 | $1.32M | +60.4% |
| 2013 | $824.0K | -36.7% |
| 2012 | $1.30M | +19.6% |
| 2011 | $1.09M | +37.0% |
| 2010 | $794.0K | -39.3% |
| 2009 | $1.31M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.0K | -95.1% | +50.0% |
| June 30, 2025 | $4.0K | -97.1% | -95.9% |
| March 31, 2025 | $97.0K | -64.3% | -20.5% |
| September 30, 2024 | $122.0K | -71.5% | -12.9% |
| June 30, 2024 | $140.0K | -75.5% | -48.5% |
| March 31, 2024 | $272.0K | +88.9% | -36.4% |
| September 30, 2023 | $428.0K | +289.1% | -25.2% |
| June 30, 2023 | $572.0K | +1942.9% | +297.2% |
- ProPhase Labs, Inc. showed a decrease of -57.6% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2024 period, ProPhase Labs, Inc.’s r&d expense has declined by 54.6% (from $1.31 million to $594.0 thousand).
- The most recent figure is from ProPhase Labs, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: